Anand A Dalal Selected Research

Cholinergic Antagonists (Anticholinergics)

6/2012	Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy.
5/2012	Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD.
1/2012	Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population.
12/2010	Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
11/2009	Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
1/2009	Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anand A Dalal Research Topics

Disease

29	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2009
12	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2018
6	Asthma (Bronchial Asthma) 01/2017 - 12/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2017
3	Allergic Rhinitis 07/2011 - 02/2008
2	Dyspnea (Shortness of Breath) 01/2015 - 06/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Nausea 01/2019
1	Fatigue 01/2019
1	Neutropenia 01/2019
1	Febrile Neutropenia 01/2019
1	Pain (Aches) 08/2018
1	Neoplasms (Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Perennial Allergic Rhinitis 07/2011
1	Seasonal Allergic Rhinitis (Hay Fever) 03/2009
1	Hypersensitivity (Allergy) 03/2009
1	Chronic Bronchitis 01/2009
1	Rhinitis 07/2008

Drug/Important Bio-Agent (IBA)

15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 02/2008
14	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 06/2012 - 01/2009
11	Hormones (Hormone)IBA 01/2019 - 01/2018
7	Tiotropium Bromide (Spiriva)FDA Link 06/2012 - 01/2009
7	Salmeterol Xinafoate (Serevent)FDA Link 12/2010 - 01/2009
6	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 06/2012 - 01/2009
6	Cholinergic Antagonists (Anticholinergics)IBA 06/2012 - 01/2009
6	Albuterol (Salbutamol)FDA LinkGeneric 06/2012 - 01/2009
6	Fluticasone (Cutivate)FDA LinkGeneric 12/2010 - 02/2008
5	ribociclibIBA 08/2019 - 06/2018
4	Letrozole (Femara)FDA LinkGeneric 01/2019 - 06/2018
4	ErbB Receptors (EGF Receptor)IBA 12/2018 - 01/2018
4	Epidermal Growth Factor (EGF)IBA 06/2018 - 01/2018
4	Nasal SpraysIBA 07/2011 - 02/2008
3	palbociclibIBA 08/2019 - 06/2018
2	Aromatase InhibitorsIBA 12/2018 - 01/2018
2	Cyclin-Dependent Kinase 4IBA 12/2018 - 06/2018
2	ceritinibIBA 01/2018 - 01/2017
2	GoldIBA 01/2015 - 01/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2010 - 10/2010
2	Histamine Antagonists (Antihistamines)IBA 03/2009 - 07/2008
2	fluticasone furoate FDA Link 03/2009 - 02/2008
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	human ERBB2 proteinIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	GlucocorticoidsIBA 01/2017
1	CrizotinibIBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 07/2016
1	IndolaprilIBA 01/2016
1	Prescription DrugsIBA 01/2016
1	ORALIT (ORS)IBA 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	insulin receptor-related receptor (IRR)IBA 01/2012
1	fexofenadine (Allegra)FDA LinkGeneric 03/2009
1	Bronchodilator Agents (Bronchodilators)IBA 01/2009
1	montelukast (Singulair)FDA Link 07/2008

Therapy/Procedure

27	Therapeutics 01/2023 - 02/2008
5	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
3	Ambulatory Care (Outpatient Care) 01/2017 - 10/2010
2	Long-Term Care 04/2014 - 10/2009
2	Patient Readmission 06/2012 - 10/2010
2	Critical Care (Surgical Intensive Care) 03/2011 - 01/2010
1	Drug Tapering 08/2019
1	Durable Medical Equipment (Medical Equipment, Durable) 04/2014
1	Duration of Therapy 06/2012
1	Treatment Delay 01/2012
1	Length of Stay 10/2010
1	Nebulizers and Vaporizers (Inhaler) 06/2010